Virtus ETF Advisers LLC Mersana Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$1.06 - $3.91 $1,089 - $4,019	-1,028 Reduced 9.03%	10,358 $13,000
Q2 2023 Aug 14, 2023	SELL	$3.08 - $9.55 $8,580 - $26,606	-2,786 Reduced 19.66%	11,386 $37,000
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $21,784 - $38,230	-5,446 Reduced 27.76%	14,172 $58,000
Q4 2022 Feb 14, 2023	SELL	$5.65 - $7.86 $87,179 - $121,279	-15,430 Reduced 44.03%	19,618 $114,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $1,152 - $1,992	249 Added 0.72%	35,048 $237,000
Q2 2022 Aug 12, 2022	BUY	$2.84 - $5.0 $18,474 - $32,525	6,505 Added 22.99%	34,799 $161,000
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $6,283 - $11,138	-1,680 Reduced 5.6%	28,294 $113,000
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $86,633 - $155,876	15,809 Added 111.61%	29,974 $186,000
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $6,394 - $10,809	-747 Reduced 5.01%	14,165 $134,000
Q2 2021 Aug 10, 2021	BUY	$13.28 - $18.07 $41,712 - $56,757	3,141 Added 26.68%	14,912 $203,000
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $3,230 - $5,595	211 Added 1.83%	11,771 $190,000
Q4 2020 Feb 12, 2021	SELL	$16.84 - $27.59 $65,743 - $107,711	-3,904 Reduced 25.25%	11,560 $308,000
Q3 2020 Nov 13, 2020	SELL	$16.2 - $25.7 $34,182 - $54,227	-2,110 Reduced 12.01%	15,464 $288,000
Q2 2020 Aug 05, 2020	BUY	$5.24 - $23.4 $92,087 - $411,231	17,574 New	17,574 $411,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $157M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.